LONDON & NEW YORK - Global law firm Reed Smith has advised Spectral MD Holdings, Ltd (Spectral MD) in connection with its recent oversubscribed placing and the admission of its shares to AIM. 
3D image concept of optical fiber

Spectral MD, a Delaware company based in Dallas, Texas, is a predictive analytics company that develops proprietary AI algorithms and optical technology for faster treatment decisions in wound care. The company has started trading on AIM after raising £11.3m by way of an oversubscribed placing of new common stock.

A Reed Smith team based in London and New York advised Spectral MD on the transaction, with the UK team advising on all aspects of English law, and preparing and negotiating the transaction documentation.  The U.S. team advised in regards to all aspects of US law, including the pre-IPO structuring of the company.